iRhythm Technologies (IRTC) Receives FDA 510(k) Clearance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
iRhythm Technologies (IRTC) PT Raised to $95 at Truist Securities
October 22, 2024 5:55 AM EDTTruist Securities analyst David Rescott raised the price target on iRhythm Technologies (NASDAQ: IRTC) to $95.00 (from $80.00) while maintaining a Buy rating.
The analyst comments "IRTC secured FDA approval for 1 of 2 anticipated ZioAT 510Ks, which is a step in the right direction, in... More
BTIG Reiterates Buy Rating on iRhythm Technologies (IRTC)
October 22, 2024 5:33 AM EDTBTIG analyst Marie Thibault reiterated a Buy rating and $125.00 price target on iRhythm Technologies (NASDAQ: IRTC).
The analyst comments "After market close on Monday, iRhythm announced they received 510(k) clearance for design updates previously made to Zio AT via... More
